Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Gabapentin Market Outlook

The global gabapentin market size was valued at USD 2.10 billion in 2023, driven by the increasing use of gabapentin as a pain reliever drug across the globe. The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 3.26 billion by 2032.

Gabapentin: Introduction

Gabapentin tablets, capsules, and oral solutions are used to control seizures of certain type by combining them with other medications. They are also used as a pain reliever for postherpetic neuralgia that are basically the sensations or body aches occurring after person has had a shingle attack. It is also used to endure the pain of diabetic neuropathies and hot flashes in women who are undergoing treatment for breast cancer or the ones that have had their menopause.

Global Gabapentin Market Analysis

The major factors aiding the market growth are the undergoing development of new formulation for gabapentin in order to enhance efficacy and adherence of patient in the gabapentin market. The growing evidence of research towards the use of gabapentin to reduce alcohol dependence could possibly contribute to the expansion of the market. The escalating adoption of telemedicine, exploration of combination therapies is among some other key trends propelling the global gabapentin market expansion.

Additionally, the increased off-label prescription of gabapentin for conditions such as anxiety disorders, insomnia, and fibromyalgia, among others is also driving the demand for gabapentin. Due to the increasing geriatric population and lifestyle changes, the prevalence of chronic pain conditions such as neuropathic pain, postherpetic neuralgia, and diabetic neuropathy has also increased, owing to the market growth as gabapentin is the main prescribed drug for the treatment of such conditions. Because of its well-known opioid-sparing properties, gabapentin can be used to treat pain along with less potent opioids.

Gabapentin can potentially treat several anxiety disorders such as bipolar disorder, and other mental health conditions, which is why it has gained attention in the market. The growing emphasis on mental health and the need for effective pharmacological interventions are directly contributing to the global gabapentin market development.

Global Gabapentin Market Segmentations

Market Breakup by Product Type

  • Capsule 
  • Tablet

Market Breakup by Application

  • Epilepsy 
  • Neuropathic Pain 
  • Restless Legs Syndrome

Market Breakup by Route of Administration

  • Oral 
  • Parenteral 
  • Intravenous

Market Breakup by Distribution Channel

  • Hospital Pharmacies 
  • Retail Pharmacies 
  • Other Distribution Channels

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Global Gabapentin Market Overview

There are several major factors that are driving the market growth such as the increasing use of gabapentin as a pain reliever drug in the market. The rising incidence of chronic pains as shingles, diabetic neuropathy, and other pains that are hard to cure with the use of basic medicines are also contributing to the market growth.

Additionally, escalating demand for generic drug development which is comparatively less expensive than the drugs that are undersigned with name of big brands is propelling the growth of the market. Some other factors driving the market growth include the affordability and availability of Gabapentin in countries that are still developing with reasonable healthcare budgets. Gabapentin is available in different form as topical gels, oral solutions, capsules, tablets, and creams, and this factor is also a major driver for the gabapentin market growth. The increase in research and development to find new applications of gabapentin and develop new formulations to enhance the efficacy is a driver owing to the market growth.

Gabapentin has also been available in generic forms, which in turn is increasing competition among generic manufacturers. This competition would probably lead to lower prices and increased availability of gabapentin, driving market growth.

Gabapentin Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Zydus Pharmaceuticals, Inc.  
  • Glenmark Pharmaceuticals Limited  
  • Sun Pharmaceutical Industries Ltd.  
  • Ascend Laboratories, LLC  
  • Apotex Inc.  
  • Teva Pharmaceutical Industries Ltd.  
  • Aurobindo Pharma.  
  • Amneal Pharmaceuticals LLC.  
  • Cipla 
  • Pfizer Inc.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Product Type
  • Capsule
  • Tablet
Breakup by Application
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Intravenous
Breakup by Distribution Channel
  • Hospital Pharmacies 
  • Retail Pharmacies 
  • Other Distribution Channels
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Zydus Pharmaceuticals, Inc.  
  • Glenmark Pharmaceuticals Limited  
  • Sun Pharmaceutical Industries Ltd.  
  • Ascend Laboratories, LLC  
  • Apotex Inc.  
  • Teva Pharmaceutical Industries Ltd.  
  • Aurobindo Pharma.  
  • Amneal Pharmaceuticals LLC.  
  • Cipla 
  • Pfizer Inc.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 2.10 billion in 2023 driven by the increasing use of gabapentin.

The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032, likely to reach a market value of USD 3.26 billion by 2032.

The escalating demand for generic drug development is major driver contributing to the market growth.

The escalating adoption of telemedicine in the market is a major trend driving the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The different types of products in the market include capsule and tablets.

It finds wide application in epilepsy, neuropathic pain, and restless legs syndrome treatments.

The routes of administrations of gabapentin include oral, parenteral, intravenous.

The different channels of distribution in the market include hospital pharmacies, retail pharmacies, among other distribution channels.

Key players involved in the market are Inc., Glenmark, Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC, Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla, Pfizer Inc., and Zydus Pharmaceuticals.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124